These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4810955)

  • 1. An assay for coagulation factor VII using factor VII-depleted bovine plasma.
    Nemerson Y; Clyne LP
    J Lab Clin Med; 1974 Feb; 83(2):301-3. PubMed ID: 4810955
    [No Abstract]   [Full Text] [Related]  

  • 2. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
    Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of canine factor VII deficient substrate plasma.
    Gaston LW; Spivack AR
    J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.
    Miller GJ; Stirling Y; Esnouf MP; Heinrich J; van de Loo J; Kienast J; Wu KK; Morrissey JH; Meade TW; Martin JC
    Thromb Haemost; 1994 Jan; 71(1):38-48. PubMed ID: 8165645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and comparison of immune-depleted and hereditary factor-VII-deficient plasmas as substrate plasmas for factor VII assays.
    Brandt JT; Triplett DA; Fair DS
    Am J Clin Pathol; 1986 May; 85(5):583-9. PubMed ID: 3518398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of residual factor VII on the sensitivity of brain thromboplastin.
    Spurling NW; Savory J
    Thromb Haemost; 1978 Jun; 39(3):592-9. PubMed ID: 705687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation factor VII. (Biochemistry, role in blood coagulation, methods of assay, congenital deficiencies and relationship with thrombosis).
    Mariani G; Mandelli F
    Ric Clin Lab; 1983; 13(3):287-98. PubMed ID: 6606207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboplastic activity of brain extracts from various species in normal plasma and in congenital factor VII deficient plasma from dogs].
    von Schaewen H
    Berl Munch Tierarztl Wochenschr; 1972; 85(8):149-52. PubMed ID: 5027610
    [No Abstract]   [Full Text] [Related]  

  • 9. [Congenital lack of factor VII (author's transl)].
    Grosse KP; Neidhardt B; Seiler G; Schricker KT; Dorn G
    Klin Padiatr; 1974 Jan; 186(1):29-33. PubMed ID: 4857999
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of factor IX in tissue thromboplastin induced coagulation.
    van den Besselaar AM; Ram IE; Alderkamp GH; Bertina RM
    Thromb Haemost; 1982 Aug; 48(1):54-8. PubMed ID: 6982540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoradiometric assays for human coagulation factor VII using polyclonal antibodies against the Ca(II)-dependent and Ca(II)-independent conformation.
    Bom VJ; van Tilburg NH; Krommenhoek-van Es C; Bertina RM
    Thromb Haemost; 1986 Dec; 56(3):343-8. PubMed ID: 2436334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to measure factor VII and factor VII activation.
    Osterud B
    Haemostasis; 1983; 13(3):161-8. PubMed ID: 6350121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of procoagulant activities in extracts of normal and malignant human tissue.
    Gordon SG; Franks JJ; Lewis BJ
    J Natl Cancer Inst; 1979 Apr; 62(4):773-6. PubMed ID: 285292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of hypoactivity of factor VII complex with an unknown cause].
    Fukase M; Iwai K; Mise N; Kubo K; Maeda T
    Nihon Rinsho; 1968 May; 26(5):1240-3. PubMed ID: 5749806
    [No Abstract]   [Full Text] [Related]  

  • 15. Report of the fifth homozygous patient with factor VII Padua defect.
    Girolami A; Dal Bo Zanon R; Caenazzo A; Scattolo N
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):447-54. PubMed ID: 6194079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of factor VII analysis in blood coagulation tests].
    Matsumoto K; Ikematsu S
    Nihon Rinsho; 1989 Dec; 48 Suppl():828-30. PubMed ID: 2622012
    [No Abstract]   [Full Text] [Related]  

  • 17. A method for the determination of activated factor VII using bovine and rabbit brain thromboplastins: demonstration of increased levels in disseminated intravascular coagulation.
    Kitchen S; Malia RG; Greaves M; Preston FE
    Thromb Res; 1988 Apr; 50(1):191-200. PubMed ID: 3400081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of tissue factor and factor VII at the earliest phase of coagulation.
    Josso F; Prou-Wartelle O
    Thromb Diath Haemorrh Suppl; 1965; 17():35-44. PubMed ID: 5874847
    [No Abstract]   [Full Text] [Related]  

  • 19. Dietary fat intake and plasma factor VII antigen concentration.
    Miller GJ; Stirling Y; Howarth DJ; Cooper JC; Green FR; Lane A; Humphries S
    Thromb Haemost; 1995 May; 73(5):893. PubMed ID: 7482423
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and blood coagulation studies in patients with congenital factor VII deficiency].
    Janczarski M
    Pol Tyg Lek; 1983 Aug; 38(31):959-62. PubMed ID: 6664914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.